Exploring the Role of MicroRNAs in Cancer Development and Progression: Implications for Targeted Therapies

Thesis Abstract

Abstract
MicroRNAs (miRNAs) are small non-coding RNA molecules that play crucial roles in the post-transcriptional regulation of gene expression. In the context of cancer development and progression, dysregulation of miRNAs has been widely implicated in various aspects of tumorigenesis, including cell proliferation, apoptosis, and metastasis. This thesis aims to explore the role of miRNAs in cancer development and progression, with a focus on their potential implications for targeted therapies. Chapter One provides an introduction to the study, presenting the background of the research topic, the problem statement, objectives, limitations, scope, significance, and structure of the thesis. The definitions of key terms related to miRNAs, cancer, and targeted therapies are also provided to establish a common understanding. Chapter Two comprises a comprehensive literature review that explores ten key aspects related to miRNAs in cancer. This section delves into the current understanding of miRNA dysregulation in different types of cancer, the mechanisms by which miRNAs regulate gene expression, and the potential clinical implications of targeting miRNAs for cancer therapy. Chapter Three outlines the research methodology employed in this study, including the selection of research participants, sample collection and analysis procedures, as well as the statistical methods used to analyze the data. Other contents include the study design, data collection methods, and ethical considerations. Chapter Four presents a detailed discussion of the findings obtained from the research, highlighting the specific miRNAs that are dysregulated in various types of cancer and their functional roles in cancer development and progression. The implications of these findings for the development of targeted therapies and personalized medicine approaches are also discussed. Chapter Five serves as the conclusion and summary of the thesis, providing a synthesis of the key findings, implications, and recommendations for future research in this field. The potential clinical applications of targeting miRNAs for cancer therapy are discussed, emphasizing the importance of personalized treatment strategies based on miRNA expression profiles. In conclusion, this thesis contributes to the growing body of knowledge on the role of miRNAs in cancer development and progression, shedding light on the potential implications for targeted therapies. By elucidating the complex interplay between miRNAs and cancer pathogenesis, this research paves the way for the development of novel therapeutic approaches that could revolutionize the treatment of cancer in the future.